GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
{iframe}https://www.reuters.com/article/us-gsk-cancer/gsks-new-pharma-head-on-lookout-for-cancer-deals-to-boost-pipeline-idUSKBN1E50WD{/iframe}